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This article is focused on improving the quality of addiction treat-
ment. Based on observations that patients are leaving treatment
too early and/or are continuing to use substances during their
care, the authors propose six actions that could help reorient and
revitalize this kind of clinical work: (1) conceptualize and treat
addictive disorders within a psychiatric/mental health framework;
(2) make thecreation of a strong therapeuticalliancea core part of
the healing process; (3) understand patients’ addictions and other
problems using models based on multiple internal parts, voices,
or modes; (4) make contingency management and the use of
positive reinforcement systems a standard and central practice in
all treatment settings; (5) envision long-term change and healing
through the lens of identity theory; and (6) integrate the growing
developments in recovery culture with formal treatment.
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Tragically, the addiction treatment system is failing to help many who are
struggling with drug and alcohol problems, despite the serious efforts and
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best intentions of those who work in the field. The purpose of this article is
to present six core treatment paradigms and techniques that could be used
as a way of reforming and improving the care of those with substance abuse
difficulties.
A SYSTEM IN CRISIS
In terms of what is required for effective treatment within the current system,
Gerstein (2004), in a review of outcome studies, specified that 6 months
of care was the threshold at which treatment in outpatient settings starts
to become effective. Hubbard (2005), in a similar review, found that at
3 months, patients will begin to experience the impact of treatment, but that
it will take one year for them to demonstrate major changes in behavior.
The National Institute on Drug Abuse (NIDA, 2009b) stated that methadone
maintenance treatment requires 12 months of participation to be effective.
Using these findings as a guideline for retention, 6 months would appear to
be the minimal amount of time that a patient should spend in nonresidential
treatment and one year should be the norm. A number of studies, large and
small, that have included treatment-as-usual conditions as a control have
uncovered various combinations of low levels of retention and high levels
of substance use (Ball et al., 2007; Peirce et al., 2006; Petry, Alessi, Marx,
Austin, & Tardif, 2005; Petry, Martin, Cooney, & Kranzler, 2000; Petry, Peirce,
et al., 2005; Silverman et al., 1996).
Although the addiction treatment field has, in general, neither acknowl-
edged the depth of the problem nor begun an all-out search for new so-
lutions, there have been some responses to this challenge. For example,
NIDA has been running the Clinical Trials Network for over a decade (Wells,
Saxon, Calsyn, Jackson, & Donovan, 2010), the Robert Wood Johnson Foun-
dation sponsored the Network for the Improvement of Addiction Treatment
or NIATx Project (Uzoigwe, 2007), and the Center for Substance Abuse
Treatment (CSAT) has been supporting the Addiction Technology Transfer
Centers (ATTC; 2011c). In turn, Carroll and colleagues (2008) began creating
effective computer-based treatment programs, and O’Brien and McLellan
(1996) argued that addictions are, in fact, a chronic, relapsing condition
and that treatment needs to move from an acute-care model to a chronic-
care model. From a more grassroots perspective, the rise of the Recovery
Movement (White, 2009; White & Kurtz, 2006) might be seen as a response
to the crisis as well.
All of these efforts may be understood as forms of progress that, for
the most part, will not conflict with what is being proposed here. However,
to more deeply and powerfully transform addiction treatment, six pragmatic
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1. Formally and comprehensively define and treat addictions as a psychi-
atric/mental health disorder.
2. Give central importance to the therapeutic alliance.
3. Conceptualize and treat patients using models based on multiplicity of
self.
4. Make contingency management a standard practice in all treatment set-
tings.
5. Understand change and healing through the lens of identity theory.
6. Integrate formal treatment with recovery culture.
It is our belief that retention and effectiveness rates will increase dramatically
as these six ideas become accepted and implemented.
ADDICTION AS A PSYCHIATRIC/MENTAL
HEALTH DISORDER
In 1950, Dr. Bob, the cofounder of Alcoholics Anonymous (AA), advised AA
members,
But there are two or three things that flashed into my mind on which
it would be fitting to lay a little emphasis; one is the simplicity of our
Program. Let’s not louse it up with Freudian complexes and things that
are interesting to the scientific mind, but have very little to do with our
actual AA work. (Dr. Bob, 2004, para. 3)
Since then, the world has changed, and what may have been advisable
and successful in a self-help group 60 years ago may not be appropriate
in a formal treatment setting today. Given our deeper understanding of the
addiction experience and the diverse problems confronting so many drug-
using individuals, it may be more than fitting to say that ‘‘Complex problems
require complex solutions’’ (Tatarsky, 2002, p. 136).
What, then, is the nature of this new understanding of addiction? The
former head of NIDA, Dr. Alan Leshner, used to say that ‘‘They should be
called patients, not clients’’ (personal communication, January 21, 2008).
By this he meant that given the growing understanding of addiction as a
brain disease, it is more appropriate to conceive of addicted individuals
as suffering from a true medical illness. Strikingly, though the addiction
treatment field has long referred to addictive disorders as a ‘‘disease,’’ this
was, in fact, more of a metaphor than an actual biological condition. The
long-standing opposition to methadone maintenance and, in some cases,
psychiatric medication, would not have occurred if the field had embraced a112 S. H. Kellogg and A. Tatarsky
‘‘true’’ disease model. If addictions were actually understood to be illnesses,
then the use of medication would have been an essential part of treatment.1
Why is this important? In a sense, all addiction treatment functions on
two axes: one of health and illness and the other of good and evil (Kellogg
& Triffleman, 1998). This means that a fundamental question that confronts
all who wish to work with those who have drug problems is: Are these
sick people who need treatment or bad people who need punishment? In
the world at large, punishment has often been a favored approach (Jacobs,
2010; Mydans,2010). Given this, the widespread adoption of the term patient
and the championing of a ‘‘true’’ disease concept will go a long way toward
humanizing treatment and improving its quality.
This ‘‘new’’disease modelis currentlybeing championed by many forces
in the field. For example, NIDA (2008) said that addiction is a ‘‘brain disease’’
and a ‘‘chronic disease’’ (NIDA, 2011). The ATTC (2011a) also agreed with
NIDA’s (2011a) perspective by affirming that it is a ‘‘brain disease,’’ that it
involves a ‘‘changed brain,’’ and that is a ‘‘chronic disorder’’ (ATTC, 2011b).
The National Institute on Alcoholism and Alcohol Abuse (2007) said that
alcoholism is a ‘‘chronic disease’’ while not saying that it is a brain disease.
Last, CSAT (2005) described it as a ‘‘medical condition,’’ as an illness, and as
a ‘‘chronic, relapsing disorder’’ (CSAT, 1994).
If an addiction is a disease, the next question is: What kind? We believe
that understanding it as a psychiatric/mental health disorder is the most
accurate and most useful way of conceptualizing this problem. In a sense it
already is one as the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV-TR; American Psychiatric Association, 2000) classifies addictive and
problematic substance use as substance dependence and substance abuse
disorders. In addition, NIDA (2009a, b) labeled it a mental illness. Given
that the disorder (1) has a strong behavioral component, (2) utilizes the
brain as its primary organ of action, (3) benefits from the development of
new medications that target or involve the brain, (4) occurs in the context
of many other psychiatric disorders, and (5) requires the same treatment
skills that are needed in other forms of psychotherapy, it clearly seems the
most appropriate paradigm to use. Last, studies have shown that 60% to
80% of patients with an addiction have another mental health disorder, and
40% to 60% of those with a mental illness also have a substance abuse
disorder (Sciacca, 2009). Above and beyond this, the rest of those who
use substances do so for reasons that may also need specific attention.
Centeringaddictiontreatment in psychiatry and mental healthalso has certain
treatment advantages. First, it provides a strong foundation for the judicious
use of addiction-relatedmedications (i.e., methadone,naltrexone,suboxone,
1It is interesting to note, in this context, that Bill W., the other cofounder of Alcoholics Anonymous,
went to Dr. Vincent Dole, the creator of methadone maintenance treatment and an AA board member,
and asked him to formulate a methadone equivalent for alcoholics (Green, Kellogg, & Kreek, 2004).Re-envisioning Addiction Treatment 113
topiramate, acamprosate, and disulfiram) and psychiatric medications, while
also providing the medical base necessary for the use of such harm reduction
and public health interventions as naloxone distribution. Second, it supports
the purposeful and creative use of the cognitive, behavioral,psychodynamic,
and experiential therapies not only in the treatment of the addiction but also
in work with the underlying causes and the co-occurring disorders.
To further advance this new understanding of addictive disorders, there
are three specific steps to consider. The first is to take action to ensure that
all who work with addictive disorders have formal training in psychotherapy
and a discipline-specific credential in addiction treatment. The second is to
merge the addiction and mental health agencies and treatment programs so
that this artificial separation, which does not serve patients, finally comes to
an end. The third is to find, create, or develop effective and deeper ways of
treating patients based on this new paradigm and understanding.
THE THERAPEUTIC ALLIANCE
As findings in the psychotherapy outcome literature (Safran & Muran, 2000)
and the drug addiction treatment literature have found (Meier, Donmall,
McElduff,Barrowclough,& Heller,2006), the connectionbetweenthe patient
and the clinician is of vital importance. In addition, a range of studies
have revealed that a strong and positive alliance can play a significant
role in improving retention rates, increasing levels of treatment completion,
and facilitating positive treatment outcomes across a variety of substances
(Bethea, Acosta, & Haller, 2008). Two of the key components for the effective
creationand maintenance of a therapeuticalliance are (1) that patients should
be treated with respect and empathy and (2) that the alliance should be a
central concern throughout the healing process (Tatarsky, 2002; Tatarsky &
Kellogg, 2010).
More specifically, a strong, positive therapeutic alliance can be healing
because (1) it provides a space or experience of safety that allows the patient
to relax and engage in a process of self-reflection, (2) it encourages ‘‘the
integration of self-regulation or self-management skills as the therapist both
models and teaches these skills and gives the patient permission to use
them’’ (Tatarsky & Kellogg, 2010, p. 125), and (3) because the pain that
underlies much substance use has interpersonal roots and these issues are
likely to come up in treatment, a strong alliance provides an opportunity for
resolving these productively.
The second part of the alliance is the therapeutic contract. What the
goals of treatment are, however, may be decided by the patient, the patient
and the therapist together, or by institutional forces—depending on the
therapeutic setting. For example, in harm reduction and harm reduction
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patient where they are at’’ and be of help in any way they can (Majoor &
Rivera, 2003; Tatarsky, 2003; Tatarsky & Kellogg, 2010). Gradualists, in turn,
believe that abstinence, ‘‘true’’ moderation, or nonaddictive use should be
the ultimate, if not immediate, goals of treatment (Kellogg, 2003; Kellogg &
Kreek, 2005).
In more institutionalsettings, treatment goals other than abstinence have
typically been unacceptable, although in some dual-diagnosis programs,
there may be a greater tolerancefor ongoingsubstance use (Bellack, Bennett,
Gearson, Brown, & Yang, 2006; Sciacca, 2009). In general, the therapeutic
alliance will be strengthened by the use of individualized treatment plans
that reflect an understanding that people entering treatment have different
histories, biological constitutions, problems, and goals.
MULTIPLICITY OF SELF
Before discussing multiplicity itself, it is useful to understand that the prag-
matics of addiction treatment can be conceptualized in terms of horizontal
and vertical interventions (Kellogg & Tatarsky, 2009). Horizontal interven-
tions are those that are specifically focused on controlling and/or discontin-
uing drug use whereas vertical interventions are used to address underlying
pathology, meaning, and suffering.
The horizontal interventions typically take two forms. The first of these
is substance use management (Bigg, 2001). Using the term broadly, it refers
to the range of harm reduction techniques that help people use drugs in
ways that are safer. In addition to such interventions as needle exchange,
this includes working with patients to change the amount of drugs that they
consume, the method in which they take them, the duration of time that
they are involved with them, the context in which the use takes place (alone
or with others), and, in some cases, the specific substances they favor. The
goal here is to help patients who continue to use substances make changes
so that they can reduce their immediate and longer term risk of death or
serious impairment. This is especially appropriate for patients who are not
willing to stop, for those who are having difficulty in their attempts to do so,
and for those who need to do depth work first (Denning, 2000).
The second horizontal intervention is relapse prevention (Marlatt &
Gordon, 1985). Although these interventions can also be adapted for harm
reduction purposes (Marlatt, 2004), they were historically associated with
efforts at abstinence.This approach involves working with patients to (1) un-
derstand how triggers and cues work, (2) identify their specific high-risk
situations and triggers—emotional and interpersonal, and (3) teach them to
manage these difficult situations using such skills as assertiveness, relax-
ation therapy, distraction, and accessing social support (Marlatt & Gordon,
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In turn, multiplicity of self, the understandingor perspective that people
have a number of internal parts, schemas, voices, modes, objects, forces,
or archetypes, is playing an increasingly important role in psychotherapy
and can be very helpful in addiction treatment (Rowan, 2010). Schema
mode therapy, an integrative psychotherapy that utilizes concepts of multiple
modes, emphasizes the ultimate goal of creating a strong healthy adult mode
(Kellogg & Young, 2006; Rafaeli, Bernstein, & Young, 2010; Young, Klosko,
& Weishaar, 2003). This is a part of the self that can (1) regulate other
internal parts (including those connected to avoidance, impulsivity, and self-
criticism); (2) interact successfully with other people; and (3) take assertive,
meaningful, and effective action in the world. Therapeutically, this means
that when using a mode model, two important goals of treatment will include
(1) giving voice to the different parts and (2) creating a strong and responsive
internal leader.
Addicted individuals frequently use the concept of multiplicity as can
be seen in the ubiquitous references to Dr. Jekyll and Mr. Hyde (Stevenson,
1967; White & Kurtz, 2006). ‘‘Once she had a drink she became unrecog-
nizable. She was like two people, like Jekyll and Hyde’’ (Rhind, 2008). In
some commonly used treatment approaches, the issue of multiplicity can be
seen as implied, if not formally explicated. With motivational interviewing
(Miller, 2000) and the decisional balance (Marlatt & Gordon, 1985), it is easy
to posit that there is a part of the person that wants to use/does not want to
change and a part that does not want to continue to use/does want positive
change. Motivational interviewing, though not using this formulation, does
seek to create an encounter between these two parts of the self that will lead
to tension and conflict, and, hopefully, a change in behavior.
Rothschild (2010) believed that people have a variety of internal parts
and that these may form complex relationships with one another. In sit-
uations in which there has been trauma, these parts may become more
disengaged from each other as patients may increasingly rely on dissociation
as a coping mechanism. As she put it, ‘‘one of the hallmarks of trauma is
dissociation, defined as a discontinuity between various aspects of self or an
inability to hold conflicting views of self at the same time’’ (p. 141).
This means that though one part of the person may be concerned about
the negativeconsequencesof his or her drug use, anotherpart may be deeply
invested in it; in fact, to this latter part it may seem to be a matter of life
and death. To work with this kind of patient, both parts, voices, or modes
need to be invited and welcomed into the session; in addition, their views
and desires need to be respected and appreciated. One complication here is
that in cases of dissociation, it is already difficult for patients to tolerate
the conscious awareness of internal ambiguity, and they will sometimes
‘‘flip’’ back and forth between the two polarities (Young et al., 2003). This
means that the part that wants to stop (1) attends the session, (2) learns the
cognitive-behavioral techniques for managing urges, and/or (3) agrees to go116 S. H. Kellogg and A. Tatarsky
to a meeting over the weekend. After leaving the session, the other part,
which was not welcomed into the therapy hour, takes over and problematic
drug and alcohol use ensues (Rothschild, 2010). In a clinical situation in
which drug use is condemned a priori, this situation may be exacerbated as
only one part will be allowed to speak.
Again, the therapeutic answer is to create a situation in which all of the
parts are welcomed into the room; one in which it is safe for them to speak
and perhaps encounter each other. ‘‘It is the therapist’s job to hear and hold
both, to be in a nonadversarial position from which she can recognize and
empathize with the multiple aspects of the patient’s self, helping to unite
them into a coherent whole’’ (Rothschild, 2010, p. 142).
In a similar vein, Tatarsky (2002, 2003) developed a complex vision of
why people use substances, and he believed that each of these factors needs
to be identified, understood, and, in some cases, treated directly.
Along these lines, substances may be used to: quell the pain of anxiety or
depression, help block intrusive traumatic memories, increase the ability
of those with attention-deficit/hyperactivitydisorder to focus, and reduce
the symptoms of psychosis. Wurmser (1978) has explored the role of the
‘‘inner critic’’ or the harsh, punitive superego in the use of substances. For
many, alcohol or drugs serve as a kind of revolt against or escape from
this experience of internal tyranny. (Tatarsky & Kellogg, 2011, p. 42)
Some patients seek to overcome a sense of inner deadness through their
use. They want to have a greater sensitivity to life, be able to experience
states of happiness and euthymia that they are not able to achieve in their
normal state of consciousness, and/or gain access to aspects of themselves
that have been dissociated or blocked off. Building on this, it is clear that
there may be a number of parts or ‘‘persons’’ inside the patient who are
using substances (see Figure 1). For example, Denning (2000) wrote about a
patient with borderline personality disorder who snorted cocaine when she
went out dancing and injected cocaine at home by herself when she was
feeling suicidal. Here the same drug is being used in different settings and
with different methods—each of which gave the use a different meaning.
Clearly, the therapist would want to engage and work with both the ‘‘Party
Girl’’ and the ‘‘Suicide Girl.’’ This is the kind of complex and sophisticated
understanding of drug use and its treatment that is necessary to move the
field to the next level. All of this also points to the fact that there is no
substitute for individual psychotherapy! In this new vision of healing, the
individual encounter, not the group, is the primary vehicle for change and
transformation.
The process of integrating the issues raised in the multiplicity discussion
with those connected to vertical interventions can perhaps best be illustrated
through a case example. Table 1 contains a patient’s decisional balance, aRe-envisioning Addiction Treatment 117
Note. This image shows five mode groups that may play a role in ongoing drug use. These
include pleasure, self-medication, biological necessity, social oppression, and addict lifestyle
and identity. Depending on the internal constellation of the patient, some or all of them may
need to be specifically addressed before the patient will be prepared to cease or change their
use of drugs.
FIGURE 1 Drug user internal mode system.
two-by-two matrix that includes the patient’s perceptions of the positive and
negative aspects of his or her drug use and the positive and negative aspects
of positive change.
Why does this patient use? First, he uses because he experiences strong
feelings of pleasure from the substances. The power of this experience,
which may, in some respects, be beyond words, is profoundly meaningful
and compelling and likely to call him back. Second, he feels some kind of
basic disconnectionfrom life; for example, some patients report that they feel
as if there is a wall or clear screen between themselves and the world. For
this patient, drugs help him break through in some way and connect to the
world and others. Third, connecting with others is not easy. He appears to be
signaling that he is socially anxious and that substances help him feel more
comfortable when in gatherings with others. In a related vein, he also feels
that his inhibitions prevent him from revealing himself in a positive way, and
that using chemicals helps to facilitate self-expression; he feels more truly
‘‘known’’ by others when he is using them. Fourth, like many patients with
addictions and other psychiatric or mental health problems, he is plagued by
voices of inner criticism—most likely driving feelings of anxiety, depression,
and self-hatred. Here, the substances serve even more directly as a form of118 S. H. Kellogg and A. Tatarsky
TABLE 1 Drug Use Decisional Balance
Decisional balance
Positives of drug use Positives of change
Immediate physical pleasure (10)
Feeling more ‘‘there’’ (10)
Feels more emotion (10)
Reduces social anxiety (6)
Shuts out inner critic voice (7)
People will know ‘‘real’’ self (7)
Mean score D 8.33
Feel a greater sense self-discipline (9)
Would be more productive (10)
Help him be more comfortable with self (8)
Greater confidence (6)
Mean score D 8.25
Negatives of drug use Negatives of change
Feels guilty (7)
Others are concerned (6)
Not as productive (10)
Feels like it is a crutch (10)
Feels bad (7)
Health problems (7)
Mean score D 7.83
Would not enjoy life as much (9)
Would be ignoring a part of himself (10)
Breaking up with something he loves—a
hard breakup (9)
Mean score D 9.33
Note. The Decisional Balance first involves asking the patient to identify the positives and negatives
of drug use and the positives and negatives of stopping or changing their use. After these forces are
identified, the patient is asked to rate the power of each one, positive or negative, on a scale of 1 to
10. Only those items that achieve a score of 6 or higher are kept. To create a metaphorical calculus
of the patient’s motivation, means are formulated for each of the four boxes. The force for continued
use is the Positives of Drug Use Mean plus the Negatives of Change Mean; the force for recovery or
change is the Negatives of Drug Use Mean plus the Positives of Change Mean. In this example, when
the ratio of forces is computed, the result is 17.66 : 16.08—which helps to illuminate the ‘‘stuck’’ position
of this patient.
self-medication—they block out these painful attacks on the self. Fifth, an
examination of the negatives of recovery shows an anticipated experience
of deep grief and loss. He fears that the hedonic qualities of his life will be
greatly diminished and that he will have to ignore an inner part or mode
that has played a significant role in his life.
If different modes are involved in the use of substances, various modes
may also be involved in their cessation. Again, using the decisional balance,
it appears that there are, respectively, a moral part, an ambitious part, a
relational part, and a healthy part. Each of these could be given a voice and
allowed to express hopes and fears. In fact, a complex dialogue could be
set up in which the patient embodies and expresses the five parts that are
connected to the use and the four parts that are concerned about it (Kellogg,
2004; Tatarsky, 2003). After several rounds of back-and-forth encounter, the
balance of power could be reassessed, and possible shifts in motivation
could be considered. With other patients, the therapist might want to add a
brain/biology mode. Integrating insights from neuroscience, it is important
to acknowledge the reality that parts of the brain may be seeking drug-Re-envisioning Addiction Treatment 119
based experiences and that biology may have imperatives beyond those of
psychology and the reasoning mind.2
CONTINGENCY MANAGEMENT
Contingency management, particularly the use of positive reinforcement
systems, has proven to be one of the most powerful psychosocial mech-
anisms for behavior change available (Higgins & Silverman, 2008). Forty
years of research have shown that when using reinforcements of significant
magnitude,clinicians can dramatically improve retention,decrease substance
use, and increase group attendance (Kellogg, Stitzer, Petry, & Kreek, 2006;
Kirby, Amass, & McLellan, 1999; Petry, 2000). It can also be helpful with
other issues such as medication compliance (Elk, 1999). Given the central
concern with retention and drug use in treatment, it is clearly time to make
the adoption of positive reinforcement systems a foundational and standard
part of care in every treatment facility.
IDENTITY THEORY
Three central and perennial questions in the treatment of addictions are
(1) Why do people change? (2) How do people change? and (3) How do
people maintain long-term abstinence, sobriety, or moderation? Although
there may be many hypotheses, identity theory stands out as a particular
useful one as it can not only help us to better understand the recovery
process, but also guide us in the strengthening of our current practices and
in the creation of new ones.
Identity theory developed out the symbolic interactionist tradition
(Stryker & Serpé, 1982). It, too, is a theory of multiplicity and, from this
perspective, individuals are understood to have several and sometimes
many identities. Christiansen (1999) identified three core components of
identity. The first is that of self-definition. For example, people may think of
themselves as farmers, athletes, mothers, and Episcopalians. Moving beyond
the level of self-definition, they are also likely to evaluate how well they are
performing these roles or fulfilling these identities.
The second is that identities have a relational and interpersonal com-
ponent. In general, identities come into being, are further elaborated, and
undergo transformation within social contexts. Last, identities, to be of value
and importance, must have an agentic quality. That is, identities are ex-
pressed through action and created by it.
2For specific thoughts on the treatment of this patient, please go to www.gradualismandaddiction.
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In general, the creation of identities occurs in a social context. This is a
creative and dialectical process in which the group influences the individual
and the individual influences the group. Typically beginning in adolescence
but throughout the life span as well, individuals can engage in ‘‘identity
projects’’ (Harré, 1983) or ‘‘identity work’’ (Deaux, 1991), a process by which
they consciously and purposefully make claim to an identity. Whether they
will be successful dependson whethertheir performancemeets the standards
of the appropriate reference group (Shibutani, 1968).
Because individuals belong to more than one social group, they have
more than one identity, and these are organized into a hierarchy of salience
or importance. The more important the identity, the more it will guide and
direct behavior (Stryker & Serpé, 1982).
The process of addiction interacts with identity in several ways. In terms
of initiation,Anderson (1998) wrote that people want roles and identitiesand
that young people, when they have difficulty accomplishing this, may seek
out ‘‘alternative social groups’’ such as ‘‘drug subcultural groups’’ (p. 253).
An ongoing and significant involvement with drugs or alcohol typically
leads to the creation of a drug user or addict identity. As substance use
becomes an increasingly important activity, it takes up more and more time,
and the addict identity comes to dominate the hierarchy; as this happens, it
often seriously damages or destroys other identities that may have existed
(i.e., worker, son, father, or wife) (Biernacki, 1986).
Two processes play a role in moving the individual toward treatment
and recovery. With role stress (Goode, 1960), drug users find that the process
of maintaining their drug addiction is getting more difficult and that their
levels of internal and external pain are becoming intolerable. Another way
of framing this is to see that the individualis failing to fulfill the requirements
of the addict identity. This may lead to temporary solutions such as taking
methadone or another opiate substitution medication so that they can lower
their tolerance and eventually return to heroin use at a more affordable level.
It may also lead to more permanent solutions such as entering a program,
joining a 12-Step Fellowship group, or finding and engaging in other social
institutions that provide meaning and identity (such as family, churches,
political movements, or schools). In his study of heroin-addicted individu-
als, Stephens (1991) concluded that role strain was a major motivation for
entering treatment.
Role conflict, in turn, occurs when the drug use is threatening the
viability of other cherished identities. Stereotypically, the man seeks out
treatment because he will lose his job, and the woman seeks out treatment
because she is afraid that she will hurt or lose her children.
It should be noted that identity transformation processes are often initi-
ated through a relationship with a member of a different social group. This
new connectionmay serve as a bridge that carries the individualfrom the old
group to a new one that will provide a new identity.In this regard, it is worthRe-envisioning Addiction Treatment 121
noting that in the 2007 AA Membership Survey, 33% reported that another
AA member was one of the most important forces leading to their coming to
AA (Alcoholics Anonymous, 2010). In turn, the 2007 Narcotics Anonymous
Membership Survey found that 58% said that an NA member was influential
in their decision to attend their first meeting (Narcotics Anonymous, 2008).
What all forms of treatment and recovery are attempting to do—directly
or indirectly—is create or reestablish viable, meaningful, and reinforcing
identities that can compete with and ultimately replace those that are based
on drug use (Biernacki, 1986; Kellogg, 1993; Kellogg & Kreek, 2005). For
middle-class and working-class patients, there may be remnants of other
identities that can be accessed to help build a new life; that is, they may
have some recovery capital available (Granfield & Cloud, 2001). However,
for those who grew up in cultures of poverty or in the underclass, the addict
identity may be the most viable one they have ever had. Here, the work will
frequently involve identity creation de novo—which may help explain why
this healing journey may be more difficult to complete.
The direct creation of a recovery identity is the central focus of the
12-Step Fellowship Programs, the therapeutic communities, and many tradi-
tional treatment programs (Biernacki, 1986; Greil & Rudy, 1984; Maxwell,
1984). The transformation of the drug-using self and/or the creation or
empowering of competing identities is frequently a project in individual
psychotherapy. Many, if not most people, with addictions who recover on
their own do so by finding social settings or identity niches that will support
other identities (Biernacki, 1986; Granfield & Cloud, 1996, 2001; Kellogg,
1994). Last, harm reduction settings also have the potential to provide new
identity possibilities that can lead to dramatic decreases in drug use (Zibbell,
2005) and, perhaps, initiate a journey of change and healing.
Given that identity processes are at work in all treatment and recovery
settings—even if they are not recognized and acknowledged—the first step
toward claiming the power of this paradigm would be for the treatment
field to acknowledge the role of identity in healing. The second would be
to consciously use identity theory in their treatment programs and aftercare
efforts (Kellogg & Tatarsky, 2010).
RECOVERY CULTURE
The Addiction Recovery Movement is, in a number of ways, a reinvocation
of some of the deepest traditions of the American and Native American self-
help and mutual aid traditions (White & Kurtz, 2006). It is also emerging in
the context of two important events in the addiction treatment field. The first
of these is the above-mentioned realization that the system has been based
on an acute-care model of treatment and that a chronic-care model is a much
more appropriate way to work with a ‘‘chronic, relapsing disease’’ (O’Brien122 S. H. Kellogg and A. Tatarsky
& McLellan, 1996). The second is the emergence of groups such as Faces and
Voices of Recovery who are seeking to give a public face to recovery and
show that people do attain freedom from their addictions (White & Kurtz,
2006).
The Recovery Movement seeks to create a broader culture of recovery—
a culture that would supplant that based on drug use and addiction (White,
2009). In this new vision, the primacy of recovering people as agents of
change would be championed, and formal treatment settings would be
seen as adjunctive and supportive of a much larger network of institutions,
social settings, self-help groups, dedicated individuals, and real and virtual
relationshipnetworksthat are each working to connect,affirm, and guide the
newly-abstinent individual on the path to recovery. This would also place a
central primacy on the experience and wisdom of those who have recovered
using many different paths.
Although these are compelling developments, it is with excitement and
trepidation that the Recovery Movement is included on this list of recom-
mended steps and practices. A fundamental issue is whether addicted in-
dividuals are best served (1) through intrapsychic/psychological treatment,
(2) the judicious use of medications, or (3) by social/group transformation.
In our formulation of treatment, there is a deep need for all three. Looking
first at its weaknesses and dangers, it is clear that a recapitulation of many
of the negative dynamics of the current system is at work in the Recovery
Movement. For example, White (2009) wrote, ‘‘Where addiction treatment
has drawn heavily from the disciplines of psychiatry, psychology, and social
work; recovery community building draws upon knowledge drawn from
public health, sociology, social movements, community development, and
community organizing’’ (p. 154).
The first part of this quote is in direct contradictionto one of the primary
points of this paper—that the addiction treatment field has opposed or been
resistant to the use of the insights, techniques, and visions of psychiatry and
psychology for decades. Instead, it has championed and based its treatment
on the beliefs and practices of self-help groups. In this regard, Wurmser
(1978) observed that many addicted individuals suffered from what he called
‘‘psychophobia’’ or a deep fear of looking at their internal life experiences.
In a striking parallel, the addiction treatment field itself has been very re-
luctant to engage with the inner world of the patient, to wrestle with, and
treat the addict’s fears, wounds, dreams, darkness, and suffering in a direct
and psychotherapeutic way, using appropriately trained and highly skilled
practitioners. Sadly, almost every mainstream treatment either avoids these
inner realities or engages with them in a shaming or punitive manner.
Recovery Movement advocates have, in essence, argued that these ap-
proaches have not worked very well and that it is time to emphasize social
and community healing. In this regard, White (2009) wrote, ‘‘Treatment is
best thought of as an adjunct of the community rather than the communityRe-envisioning Addiction Treatment 123
being viewed as an adjunct of treatment’’ (p. 152). The reality is that the
field is just on the cusp of actually engaging with a true psychiatric/mental
health/medical model of addiction treatment. Again, for the work to become
much more effective, the field will need to embrace the central importance
of a profound clinical and psychotherapeutic engagement with each patient.
Again, this means that there is no substitute for individual psychotherapy.
Moving beyond this, there are obviously great benefits for addicted in-
dividuals in the Recovery Movement and in the creation of Recovery Culture.
Certainly these kinds of networks can provide identity materials (Biernacki,
1986) and identity niches (Kellogg, 1994) that would help them to success-
fully claim a recovery identity and hopefully many others as well.
One very powerful metaphor for this movement is The Healing Forest
image that is part of the Native American Wellbriety Movement (Coyhis &
Simonelli, 2006; White 2009).
In this metaphor, a forest is filled with malnourished trees that are slowly
dying:::: A single tree is removed from the forest, cared for, and nursed
back to health in nutrient-rich soil with plenty of sunlight:::: Once the
tree is well, it is brought back to its forest and replanted. At first, the tree
stands firmly:::: Yet slowly it begins to wither once again—the other
trees ::: are, after all, contaminated with illness:::: What is needed
then is an environment conducive to recovery that will allow all the
trees to thrive—what Coyhis refers to as a ‘‘Healing Forest.’’ (Gryczynski,
Johnson, & Coyhis, 2007, pp. 475–476)
In short, the healing of the addicted individual and the healing of the drug-
and alcohol-ravaged community are intertwined (Coyhis & Simonelli, 2006).
Looking at this more broadly, a national social movement that creates a
vibrant recovery culture and that successfully advocates for the moderate
use of substances as a social norm would only be for the good.
CONCLUSION
The motivation for this article was a deep concern that the addictions treat-
ment field is failing to heal its patients. Of the six points presented, one is
paradigmatic (addiction is a psychiatric disorder), three combine the clinical
and the conceptual(multiplicity of self, identity theory,and recoveryculture),
and two involve the conscious use of mechanisms of change (therapeutic
alliance and contingency management). The identification and championing
of these perspectives and techniques will not, necessarily, be easy to imple-
ment; we do believe, however, that they will serve as a rich source of clinical
creativity and power. It is our hope that they will be not only be adopted
and implemented quickly, but also they will serve to inspire others to take
dramatic and effective action to improve our system of care. In the end, the124 S. H. Kellogg and A. Tatarsky
essence of psychiatry, clinical psychology, and psychotherapy is a mixture
of science, art, and love, and this is best realized in the ‘‘sacred space’’ of
the individual therapeutic encounter. This is what addicted patients want, it
is what they need, and it is what they deserve.
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